Incyte Corporation (Nasdaq: INCY) has announced a change in the timing of its presentation at the Citi 2024 Global Healthcare Conference, moving it from the afternoon to the morning of December 3, 2024. This adjustment coincides with ongoing speculation surrounding a potential buyout of Merck & Co. (MRK), which has led to increased interest in Incyte's presentation schedule. Notably, Incyte's new presentation time overlaps with that of Bristol-Myers Squibb (BMY), raising further questions about the implications of these scheduling changes. The investor conference is set to take place in Miami, although there are hints that Incyte may not be attending in person.